Source: PIB Contents1 What is the News?2 About BBV154:3 About Mission COVID Suraksha 4 About BIRAC What is the News? BBV154, the first Nasal Vaccine against Covid-19 has received the regulator’s nod for conducting Phase 2 and 3 clinical trials. About BBV154: BBV154 is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine. It is the first… Continue reading First Nasal Vaccine Developed by Bharat Biotech supported by DBT-BIRAC gets nod of regulator for Phase 2 Trial
Tag: nasal vaccine
Search Articles
Latest Articles
- 10 PM UPSC Current Affairs Quiz 28 March, 2024
- 9 PM UPSC Current Affairs Articles 28 March, 2024
- India’s urban water crisis-From Bengaluru to Chennai and beyond
- Limitation of Welfare Policies Politics in India
- Challenges of implementing a wealth tax: Piketty’s wealth tax: An idea that just can’t work
- Avoid pre-trial injunctions against the media in defamation cases: Timely restatement
- Impact of politics on humanitarian aid: The politics of humanitarian aid
- Investment Facilitation for Development (IFD): WTO’s investment facilitation negotiations are not illegal
- Sustainable building materials
- [Download] New 10 PM Weekly Compilation – March 2024 – 3rd week